Mgc Pharmaceuticals Ltd. (AU:RGT) has released an update.
Argent Biopharma Limited has announced the cessation of a batch of options due to expiry without exercise or conversion. Specifically, 166,042 options expiring on April 12, 2024, with an exercise price of $12.00, have ceased as of that date, according to the company’s recent securities update.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
